Australia markets closed

Purple Biotech Ltd (PPBT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5254-0.0186 (-3.42%)
At close: 04:00PM EDT
0.5288 +0.00 (+0.65%)
After hours: 04:15PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-19,880
-19,880
-21,668
-18,384
-27,999
Depreciation & amortisation
197
197
201
231
235
Stock-based compensation
1,875
1,875
2,412
2,082
2,645
Change in working capital
274
274
3,255
744
-3,438
Accounts receivable
-
-
313
-316
-492
Accounts payable
1,334
1,334
799
399
-2,355
Other working capital
-19,928
-19,928
-16,963
-15,366
-12,248
Other non-cash items
-2,294
-2,294
-843
-108
15,462
Net cash provided by operating activities
-19,925
-19,925
-16,735
-15,251
-12,092
Cash flows from investing activities
Investments in property, plant and equipment
-3
-3
-228
-115
-156
Acquisitions, net
0
-3,549
0
0
-
Purchases of investments
-
-
-
0
-49,619
Sales/maturities of investments
1,511
16,678
19,818
13,162
-
Other investing activities
-
-
-
-
1
Net cash used for investing activities
13,881
13,881
19,914
13,406
-49,595
Cash flows from financing activities
Debt repayment
-168
-168
-165
-153
-179
Common stock issued
1,563
1,563
1,498
564
27,925
Dividends paid
0
0
0
0
0
Other financing activities
-890
-890
-152
-24
-5,355
Net cash used provided by (used for) financing activities
5,449
5,449
1,114
1,512
68,488
Net change in cash
-595
-595
4,293
-333
6,801
Cash at beginning of period
15,030
15,030
10,890
11,247
4,385
Cash at end of period
14,489
14,489
15,030
10,890
11,247
Free cash flow
Operating cash flow
-19,925
-19,925
-16,735
-15,251
-12,092
Capital expenditure
-3
-3
-228
-115
-156
Free cash flow
-19,928
-19,928
-16,963
-15,366
-12,248